You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neoplasm, prostate cancer,

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Malignant Tumor of Prostate, Secondary Malignant Tumor of Prostate Trial in Cleveland (drug, other, radiation)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Androgen deprivation therapy (ADT)
  • +3 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center Seidman Cancer Cen
Nov 21, 2023

Prostatic Tumor, Adenocarcinoma, Tumor Recurrence Trial in Rennes, Pointe-à-Pitre (Standard care)

Recruiting
  • Prostatic Neoplasm
  • +3 more
  • Standard care
  • Rennes, Ille-et-Vilaine, France
  • +1 more
Sep 14, 2023

Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)

Not yet recruiting
  • Metastasis Castration Resistant Prostate Cancer(mCRPC)
  • (no location specified)
Aug 14, 2023

Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial (other, radiation, procedure)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Risk Map Decision Support System (DSS).
  • +2 more
  • (no location specified)
Jan 25, 2023

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
Has Results
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

Prostate Cancer With =10 Bone Metastases Trial (Apalutamide, 89Sr, Luteinizing Hormone-Releasing Hormone Analog)

Not yet recruiting
  • Prostate Cancer With ≤10 Bone Metastases
  • (no location specified)
Feb 22, 2023

Prostate Cancer, Prostate Tumor Trial in Nijmegen, Amsterdam (Ultrahypofractionated MR-guided radiotherapy boost)

Not yet recruiting
  • Prostate Cancer
  • Prostate Neoplasm
  • Ultrahypofractionated MR-guided radiotherapy boost
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Nov 3, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
  • +1 more
Sep 20, 2022

Protein Kinase A in Prostate Cancer Tissue.

Not yet recruiting
  • Prostate Neoplasm
  • +2 more
  • prostate biopsy
  • (no location specified)
Jul 14, 2022

Prostate Cancer Trial in Utrecht (PSMA-PET/CT response evaluation)

Not yet recruiting
  • Prostate Cancer
  • PSMA-PET/CT response evaluation
  • Utrecht, Netherlands
    Roderick van den Bergh
Sep 10, 2022

Biochemical Recurrence of Malignant Tumor of Prostate, Prostate Cancer, BCR Prostate Carcinoma Trial in China (68Ga-PSMA-11,

Not yet recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • +2 more
  • Changsha, China
  • +5 more
Apr 26, 2023

Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +7 more
  • Biopsy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Adenocarcinoma Trial in

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +5 more
  • Questionnaire Administration
  • Tin Sn 117m Pentetate
  • Lexington, Kentucky
    University of Kentucky/Markey Cancer Center
Nov 26, 2022

Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic

Not yet recruiting
  • Metastatic Malignant Neoplasm in the Viscera
  • +4 more
  • Lutetium Lu 177 Dotatate
  • (no location specified)
Jan 25, 2023

Strength, Aging, and Memory in Prostate Cancer

Active, not recruiting
  • Prostate Neoplasm
  • Prostate Cancer
  • Androgen deprivation therapy
  • Omaha, Nebraska
    University of Nebraska Medical Center
Jul 13, 2022

[18F]FPSMA-1007 PET/CT in Suspected Prostate Cancer Patient

Not yet recruiting
  • Prostate Cancer
  • Prostate Neoplasm
  • Taichung, Taiwan
  • +1 more
Jun 16, 2022

Prostatic Tumor Trial in France (prostate biopsy, Urinary sampling, Rectal swabbing before biopsies are performed)

Recruiting
  • Prostatic Neoplasm
  • prostate biopsy
  • +2 more
  • Cannes, France
  • +3 more
May 13, 2022

Urologic Cancer, Biochemical Recurrence of Malignant Tumor of Prostate Trial in Freiburg (Pembrolizumab Injection [Keytruda],

Recruiting
  • Urologic Cancer
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Pembrolizumab Injection [Keytruda]
  • Salvage Radiation Therapy (SRT)
  • Freiburg, Baden-Württemberg, Germany
    Clinic of Urology, Medical Center - University of Freiburg
Nov 7, 2022

SLPI for Prostate Cancer

Recruiting
  • Prostate Cancer
  • Prostatic Neoplasm
  • Secretory leukocyte protease inhibitor (SLPI) in prostate cancer
  • +2 more
  • Florence, Tuscany, Italy
    Careggi University Hospital
May 6, 2022

Drug-drug Interactions in Patients Treated With Anticancer

Recruiting
  • Prostatic Neoplasm
  • data collection
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
Nov 9, 2022

Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)

Recruiting
  • Metastatic Prostate Cancer
  • +4 more
  • M7824
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Prostate-Specific Membrane Antigen PET Scans in People Prostate

Recruiting
  • Prostate Cancer
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 29, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston

Completed
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +5 more
  • Durvalumab
  • Tremelimumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2022

Prostate Adenocarcinoma, Prostate Cancer, Prostate Tumor Trial in Leuven, Amsterdam, Nijmegen (Hypo-FLAME 2.0 study)

Active, not recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Hypo-FLAME 2.0 study
  • Leuven, Belgium
  • +2 more
Jun 7, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

Active, not recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022